Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching-Reference-Cited by-同舟云学术

Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching

Published:2019-12-06 Issue:1 Volume:50 Page:75-83
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Tada Toshifumi¹^ORCID,Kumada Takashi¹,Hiraoka Atsushi²^ORCID,Michitaka Kojiro²,Atsukawa Masanori³,Hirooka Masashi⁴,Tsuji Kunihiko⁵,Ishikawa Toru⁶,Takaguchi Koichi⁷,Kariyama Kazuya⁸,Itobayashi Ei⁹,Tajiri Kazuto¹⁰^ORCID,Shimada Noritomo¹¹,Shibata Hiroshi¹²,Ochi Hironori¹³,Toyoda Hidenori¹,Nouso Kazuhiro⁸,Tsutsui Akemi⁷,Nagano Takuya⁷,Itokawa Norio³,Hayama Korenobu³,Imai Michitaka⁶,Joko Kouji¹³^ORCID,Koizumi Yohei⁴,Hiasa Yoichi⁴^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology Ogaki Municipal Hospital, Ogaki Japan

2. Gastroenterology Center Ehime Prefectural Central Hospital Matsuyama Japan

3. Division of Gastroenterology and Hepatology, Department of Internal Medicine Nippon Medical School Tokyo Japan

4. Department of Gastroenterology and Metabology Ehime University Graduate School of Medicine Matsuyama Japan

5. Center of Gastroenterology Teine Keijinkai Hospital Sapporo Japan

6. Department of Gastroenterology Saiseikai Niigata Daini Hospital Niigata Japan

7. Department of Hepatology Kagawa Prefectural Central Hospital Takamatsu Japan

8. Department of Gastroenterology Okayama City Hospital Okayama Japan

9. Department of Gastroenterology Asahi General Hospital Asahi Japan

10. Department of Gastroenterology Toyama University Hospital Toyama Japan

11. Division of Gastroenterology and Hepatology Otakanomori Hospital Kashiwa Japan

12. Department of Gastroenterology Tokushima Prefectural Central Hospital Tokushima Japan

13. Hepato‐biliary Center Matsuyama Red Cross Hospital Matsuyama Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13427

Reference22 articles.

1. AASLD guidelines for the treatment of hepatocellular carcinoma

2. World Health Organization.GLOBOCAN Cancer Fact Sheets: liver Cancers. Available at:http://globocan.iarc.fr/old/FactSheets/cancers/liver‐new.asp. Accessed on May 27 2019.

3. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overall survival was inferior in octogenarians with early-stage hepatocellular carcinoma undergoing percutaneous radiofrequency ablation.;2024-01-30

2. Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma;Targeted Oncology;2024-01

3. Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival;Cancer Medicine;2023-12

4. Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma;Liver Cancer International;2023-09

5. Endocrine-related adverse conditions induced by tyrosine kinase inhibitors;Annales d'Endocrinologie;2023-05